论文部分内容阅读
目的探索在肝硬化患者的临床诊断中,生化检验项目的具体价值。方法选择我院于2015年2月~2016年4月收治的72例肝硬化患者作为检验组,再选择同时间段内在我院接受身体检查的72名健康人群作为参照组,对两组对象分别进行生化检验,对比两组对象的检验结果情况。结果检验组患者的白蛋白与胆碱酯酶明显低于参照组,但是其他生化检验指标均高于参照组,两组对象的相关数据接受组间对比存在明显差异(P<0.05)。结论对于肝硬化患者的临床诊断而言,生化检验项目具有极高的应用价值,值得推广。
Objective To explore the specific value of biochemical test items in the clinical diagnosis of patients with cirrhosis. Methods Seventy-two patients with cirrhosis who were admitted to our hospital from February 2015 to April 2016 were selected as the test group and 72 healthy subjects in our hospital during the same period as the reference group. The subjects were divided into two groups Biochemical test, comparing the test results of two groups of objects. Results The levels of albumin and cholinesterase in the test group were significantly lower than those in the reference group, but the other biochemical indexes were higher than those in the reference group. There was significant difference (P <0.05) between the two groups. Conclusion For the clinical diagnosis of patients with cirrhosis, biochemical test items have a very high value, it is worth promoting.